发明名称 Fused ring 4-oxopyrimidine derivative
摘要 The present invention provides a compound represented by formula (I) below, or a pharmaceutically acceptable salt thereof, which, having histamine H3 receptor antagonist or inverse agonist activity, is useful in the prophylaxis or therapy of metabolic diseases, circulatory diseases, or nervous system diseases. [where, for example, Ar is a divalent group formed by eliminating two hydrogen atoms from benzene, X1 is a nitrogen atom, sulfur atom or oxygen atom, R1 is a 5- to 6-membered heteroaryl group, Ring A is a 5- to 6-membered heteroaryl ring, R2 and R3 are amino groups or alkylamino groups, and X2 is represented by formula (II): (where R4 and R5 are lower alkyl groups, and n is an integer from 2 to 4).]
申请公布号 US7521455(B2) 申请公布日期 2009.04.21
申请号 US20050058444 申请日期 2005.02.14
申请人 BANYU PHARMACEUTICAL CO. LTD. 发明人 NAGASE TSUYOSHI;SATO NAGAAKI;KANATANI AKIO;TOKITA SHIGERU
分类号 A61K31/517;A61K31/47;A61K31/4725;A61K31/519;A61K31/55;A61K45/06;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P3/12;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P19/06;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07D217/24;C07D239/70;C07D239/91;C07D401/04;C07D401/12;C07D403/04;C07D403/12;C07D471/04;C07D487/04;C07D487/08 主分类号 A61K31/517
代理机构 代理人
主权项
地址